SLC5A2 and type 2 diabetes mellitus: In addition, research suggests that inhibiting SGLT-2 modifies the expression and activity of the NLRP3 inflammasome, which in turn has a favorable effect on renal function in mice with type 2 diabetes mellitus [20].